The Diabetes Prevention Program (DPP) remains the gold standard when it comes to preventing the progression from prediabetes to type 2 diabetes. However, the actual uptake of the program remains unacceptably low – despite its proven effectiveness. American researchers investigated whether a fully automated DPP program based on artificial intelligence (AI) can deliver results comparable to those of a traditional human-led program.
Autoren
- Jens Dehn
Publikation
- InFo DIABETOLOGIE & ENDOKRINOLOGIE
Related Topics
You May Also Like
- Artificial intelligence in diabetes prevention
Lifestyle interventions are better accepted with AI
- B-cell lymphomas
Bispecific antibodies – mechanisms, evidence and future role
- Dermatoscopic findings of granulomatous diseases
Cutaneous sarcoidosis, necrobiosis lipoidica and granuloma anulare
- Clostridioides difficile infection: specific therapy
Importance of vancomycin and fidaxomicin has increased
- Study report
Asthma exacerbation risk in patients with a psychological comorbidity
- Neuropathies - CIDP
Differentiate chronic inflammatory demyelinating polyneuropathy (CIDP)
- Treatment of type 2 diabetes: paradigm shift continues
Cardiorenal organ protection is increasingly coming to the fore
- Semaglutide and tirzepatide in HFpEF and T2D/obesity